Mersana Therapeutics buy Guggenheim
Start price
16.05.25
/
50%
€0.31
Target price
16.05.26
€4.46
Performance (%)
-14.13%
Price
25.07.25
€0.26
Summary
This prediction is currently active. The prediction for Mersana Therapeutics disappoints with a performance of -14.13%. This prediction currently runs until 16.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mersana Therapeutics | - | - |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by Guggenheim for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $5.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat